Praxis Precision Medicines, Inc. - PRAX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G | ORBIS INVESTMENT MANAGEMENT LTD | 5.0% | 1,252,573 | View |
| Feb 17, 2026 | SCHEDULE 13G | Allan Gray Australia Pty Ltd | 0.0% | 2,589 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 7.2% | 1,995,986 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Joseph Edelman | 7.2% | 1,995,986 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 7.2% | 1,995,986 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 5.9% | 1,503,376 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 5.9% | 1,503,376 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Point72 Biotech Private Investments, LLC | 0.3% | 65,933 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Differentiated Ventures Investments, LLC | 0.3% | 65,933 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | 72 Investment Holdings, LLC | 0.3% | 65,933 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 6.1% | 1,569,309 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 3.83% | 965,313 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Robert Atchinson | 3.83% | 965,313 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Phillip Gross | 3.83% | 965,313 | View |
| Feb 05, 2026 | SCHEDULE 13G | FMR LLC | 5.4% | 1,353,275 | View |
| Feb 05, 2026 | SCHEDULE 13G | Abigail P. Johnson | 5.4% | 1,353,275 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Cormorant Asset Management, LP | 4.0% | 1,000,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Bihua Chen | 4.0% | 1,000,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | T. Rowe Price Associates, Inc. | 4.8% | 1,003,545 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 9.3% | 2,007,016 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 9.3% | 2,007,016 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Point72 Biotech Private Investments, LLC | 0.3% | 65,933 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Differentiated Ventures Investments, LLC | 0.3% | 65,933 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | 72 Investment Holdings, LLC | 0.3% | 65,933 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Steven A. Cohen | 9.6% | 2,072,949 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 12.3% | 2,763,859 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Janus Henderson Biotech Innovation Master Fund Ltd | 6.2% | 1,379,790 | View |
| Nov 03, 2025 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 5.29% | 1,305,175 | View |
| Nov 03, 2025 | SCHEDULE 13G/A | Robert Atchinson | 5.29% | 1,305,175 | View |
| Nov 03, 2025 | SCHEDULE 13G/A | Phillip Gross | 5.29% | 1,305,175 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.